For RA Elders, Is There a Better Target Than TNF?
(MedPage Today) -- Older patients with rheumatoid arthritis (RA) who were treated with interleukin (IL)-6 inhibitors were less likely to stop treatment than those given tumor necrosis factor (TNF) inhibitors, Japanese investigators reported.
After...
Read more »